Stempoint Capital »

Lipocine shares owned by Stempoint Capital

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 160k 7.99

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Praxis Precision Medicines I Com New (PRAX)
Surrozen Com New (SRZN)
Mbx Biosciences (MBX)
Mbx Biosciences (MBX)
Mineralys Therapeutics (MLYS)
Mineralys Therapeutics (MLYS)
Enliven Therapeutics (ELVN)
Enliven Therapeutics (ELVN)
Cg Oncology (CGON)
Cg Oncology (CGON)
Biohaven (BHVN)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Diadema Partners
Vanguard Group
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Renaissance Technologies
Two Sigma Investments

View all funds holding Lipocine